NIH-funded research R01 grant

Investigating genetic factors that influence retinal diseases

Official title: Genetic Modifiers of Retinal Disease

Funded at Jackson Laboratory · NIH-11046663 · Data updated 2026-11-12

This study is looking at how changes in the CRB1 gene can cause eye conditions like Leber Congenital Amaurosis and retinitis pigmentosa, and it aims to find out how genetics and the environment can influence the different ways these conditions show up in people, so we can better understand and help those affected.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJackson Laboratory
NIH-funded
Lab location1 site (Bar Harbor, United States)
Project startMarch 1, 2022
Project endFebruary 28, 2027
Funding year2025
Award (this year)$616,564
NIH project number5R01EY027305-08
Project IDNIH-11046663 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Leber Congenital Amaurosis or retinitis pigmentosa, particularly those with CRB1 gene mutations.

Less likely to help

Patients with retinal diseases not associated with genetic mutations or those without a family history of heritable retinal disorders may not benefit from this research.

What this research studies

This research focuses on understanding heritable retinal disorders, particularly those caused by mutations in the CRB1 gene, which can lead to conditions like Leber Congenital Amaurosis and retinitis pigmentosa. The study aims to explore how genetic background and environmental factors may affect the variability in disease presentation among patients. By analyzing different genetic modifiers, the research seeks to uncover the reasons behind the diverse symptoms and progression of these retinal diseases. This could involve genetic testing and detailed patient assessments to correlate genetic information with clinical outcomes.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and potential new treatments for patients with heritable retinal disorders.

How similar studies have gone: Previous research has shown promise in understanding genetic modifiers in other heritable diseases, suggesting potential for success in this area as well.

Where this research is happening

  • Jackson Laboratory
    Bar Harbor, United States
    Active

Researchers

  • Principal investigator: Nishina, Patsy M — Jackson Laboratory
  • Study coordinator: Nishina, Patsy M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.